Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Mol Sci ; 25(15)2024 Jul 27.
Article in English | MEDLINE | ID: mdl-39125764

ABSTRACT

NIBV is an acute and highly contagious virus that has a major impact on the poultry industry. Wogonin, as a flavonoid drug, has antiviral effects, but there have been no reports indicating its role in renal injury caused by NIBV infection. The aim of this study is to investigate the antiviral effect of wogonin against NIBV. Renal tubular epithelial cells were isolated and cultured, and divided into four groups: Con, Con+Wog, NIBV and NIBV+Wog. We found that wogonin significantly inhibited the copy number of NIBV and significantly alleviated NIBV-induced cell apoptosis and necrosis. Moreover, wogonin inhibited the reduction in mitochondrial membrane potential and the aberrant opening of mPTP caused by NIBV. In conclusion, wogonin can protect renal tubular epithelial cells from damage by inhibiting the replication of NIBV and preventing mitochondrial apoptosis and necroptosis induced by NIBV.


Subject(s)
Apoptosis , Chickens , Epithelial Cells , Flavanones , Kidney Tubules , Necroptosis , Animals , Flavanones/pharmacology , Epithelial Cells/drug effects , Epithelial Cells/virology , Epithelial Cells/metabolism , Necroptosis/drug effects , Apoptosis/drug effects , Kidney Tubules/virology , Kidney Tubules/drug effects , Kidney Tubules/cytology , Kidney Tubules/pathology , Membrane Potential, Mitochondrial/drug effects , Antiviral Agents/pharmacology , Mitochondria/drug effects , Mitochondria/metabolism , Coronavirus Infections/virology , Coronavirus Infections/drug therapy , Poultry Diseases/virology , Poultry Diseases/drug therapy , Virus Replication/drug effects , Cells, Cultured
2.
Int J Biol Macromol ; 274(Pt 1): 133284, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38906344

ABSTRACT

Cell migration regulated by Thrombospondin 2 (THSB2) is important for the development of pulmonary artery remodeling, but the mechanism by which THBS2-mediated cell migration regulates the development of pulmonary artery remodeling in broiler ascites syndrome (AS) is unclear. In addition, the lack of chicken THBS2 antibodies makes it difficult to study the mechanism in depth. In our study, we used recombinant gene technology, protein purification, and other techniques to obtain mouse anti-chicken THBS2 antibody and analyze its expression in broilers, ascites broilers and other animals. The results showed that we immunized mouse with recombinant THBS2 protein and obtained an antibody titer of 1:204,800, and the addition of astragalus polysaccharide as an immunomodulator during immunization significantly increased the titer of the antibody. Western blotting (WB) and immunofluorescence results showed that the THBS2 was significantly down-regulated in the ascites broiler. The THBS2 antibody we prepared can also detect THBS2 protein in duck, mouse, goat, and rabbit tissues. These results provide a foundation for further investigation of the role of THBS2 in pulmonary artery remodeling in broiler ascites syndrome and a powerful tool for studying the role of THBS2 in AS.


Subject(s)
Antibodies , Chickens , Hypertension, Pulmonary , Recombinant Proteins , Thrombospondins , Animals , Recombinant Proteins/immunology , Thrombospondins/immunology , Thrombospondins/genetics , Mice , Hypertension, Pulmonary/immunology , Antibodies/immunology , Ascites/immunology , Pulmonary Artery , Poultry Diseases/immunology
3.
Int J Biol Macromol ; 271(Pt 2): 132515, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38768912

ABSTRACT

p62, also known as SQSTM1, has been shown to be closely related to the coronavirus. However, it remains unclear on the relationship between p62 and NIBV infection. Moreover, there are no available antibodies against the chicken p62 protein. Thus, this study aimed to prepare p62 polyclonal antibody and investigate the correlation between the p62 protein and NIBV infection. Here, PET-32a-p62 prokaryotic fusion expression vector was constructed for prokaryotic protein expression, and then p62 polyclonal antibody was prepared by immunizing rabbits. Lastly, these antibodies were then utilized in Western blotting (WB), immunohistochemistry (IHC), and immunofluorescence (IF) assays. The results showed that we successfully prepared chicken p62 polyclonal antibody. Meanwhile, WB and IF demonstrated that the expression of p62 showed a trend of first increase and then decrease after NIBV infection. IHC showed that the expression of p62 in the spleen, lung, kidney, bursa of Fabricius and trachea of chickens infected with NIBV in 11 dpi was significantly higher than that of normal chickens. Taken together, this study successfully prepared a polyclonal antibody for chicken p62 protein and confirmed its application and expression in chickens, as well as the expression of p62 in tissues after NIBV infection.


Subject(s)
Chickens , Coronavirus Infections , Infectious bronchitis virus , Animals , Infectious bronchitis virus/immunology , Coronavirus Infections/immunology , Coronavirus Infections/virology , Poultry Diseases/immunology , Poultry Diseases/virology , Sequestosome-1 Protein/metabolism , Sequestosome-1 Protein/immunology , Sequestosome-1 Protein/genetics , Antibodies/immunology , Rabbits , Antibodies, Viral/immunology
4.
Int J Biol Macromol ; 262(Pt 2): 129982, 2024 Mar.
Article in English | MEDLINE | ID: mdl-38354941

ABSTRACT

Oral vaccines are a safe and convenient alternative to injected vaccines and have great potential to prevent major infectious diseases. However, the harsh gastrointestinal (GI) environment, mucus barriers, low immunogenicity, and lack of effective and safe mucosal adjuvants are the major challenges for oral vaccine delivery. In recent years, nanoparticle-based strategies have become attractive for improving oral vaccine delivery. Here, the dendritic fibrous nano-silica (DFNS) grafted with Cistanche deserticola polysaccharide (CDP) nanoparticles (CDP-DFNS) were prepared and investigated how to impact the immune responses. CDP-DFNS facilitated the antigen uptake in mouse bone marrow-derived dendritic cells (BMDCs), and induce the activation of DCs in vitro. Furthermore, in vivo experiments, the result showed that the uptake efficiency by Peyer's patches (PPs) of CDP-DFNS/BSA was the best. And CDP-DFNS/BSA then significantly activated the DCs in lamina propria (LP), and T/B cells in PPs and mesenteric lymph nodes (MLNs). Moreover, the memory T cell responses in later period of vaccination was stronger than other groups. In addition, CDP-DFNS/BSA enhanced BSA-specific antibody IgG, IgA production, and SIgA secretion, was effective at inducing a strong mixed Th1/Th2 response and mucosal antibody responses. These results indicated that CDP-DFNS deserves further consideration as an oral vaccine adjuvant delivery system.


Subject(s)
Cistanche , Vaccines , Animals , Mice , Adjuvants, Vaccine , Silicon Dioxide , Mucous Membrane , Adjuvants, Immunologic/pharmacology , Adjuvants, Pharmaceutic , Polysaccharides/pharmacology , Immunity, Mucosal
SELECTION OF CITATIONS
SEARCH DETAIL